(Q21195659)

Dimensions Publication ID

Dimensions

17 August 2022

Ravinder N Maini

2

Ravinder N

Maini

1 reference

Dimensions Publication ID

Dimensions

1021300695

Arthritis Research and Therapy

17 August 2022

language of work or name

English

0 references

publication date

28 July 2006

9 references

13 March 2019

17 June 2019

30 June 2019

31 July 2019

27 September 2019

27 November 2019

13 December 2019

15 December 2019

14 November 2020

9 references

13 March 2019

17 June 2019

30 June 2019

31 July 2019

27 September 2019

27 November 2019

13 December 2019

15 December 2019

14 November 2020

8 Suppl 2

0 references

issue

Suppl 2

0 references

page(s)

S5

0 references

cites work

Do we need new treatment that goes beyond tumor necrosis factor blockers for rheumatoid arthritis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226077

CD44 is a determinant of inflammatory bone loss

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226077

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226077

B-lymphocyte depletion therapy in rheumatoid arthritis and other autoimmune disorders

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226077

Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226077

Interleukin 6 and its receptor: ten years later

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226077

Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226077

Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226077

Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3226077

Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid

29 November 2018

1 reference

12 December 2020

Cytokine production by synovial T cells in rheumatoid arthritis

1 reference

12 December 2020

Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis

1 reference

12 December 2020

Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition

1 reference

12 December 2020

Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate

1 reference

12 December 2020

Identifiers

DOI

10.1186/AR1969

1 reference

Dimensions Publication ID

1021300695

0 references

Fatcat ID

release_aikvtfrgyjbrpbcnsjbc4ay2yq

0 references

1 reference

1 reference

PubMed publication ID

16899109

1 reference